Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,002,623
-
Share change
-
-558,357
-
Total reported value
-
$60,875,954
-
Put/Call ratio
-
34%
-
Price per share
-
$60.71
-
Number of holders
-
44
-
Value change
-
-$33,883,025
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2019
As of 31 Mar 2019,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,002,623 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CLS Investments, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, Cerity Partners LLC, LPL Financial LLC, and OPPENHEIMER & CO INC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.